Site Members can sign up for company wide alerts
Investigation Overview
Jan. 23, 2013 (Shareholders Foundation) -- An investigation on behalf of investors in MAP Pharmaceuticals Inc. (NASDAQ:MAPP) shares was announced concerning whether the offer by Allergan, Inc to acquire MAP Pharmaceuticals Inc. for $25.00 per NASDAQ:MAPP share and the takeover process are unfair to investors in NASDAQ:MAPP shares. The investigation by a law firm concerns whether certa...
You must register (for free) or login to view the entire investigation.